Brigitte Smith insider trades: Viveve Medical (PLCSD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brigitte reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 23, 2014 | PLCSD | ↑ Buy | 947,872 | $0.53 | $502K | Indirect | Sep 30, 2014 (7d) |
| Sep 23, 2014 | PLCSD | ↑ Buy | 192,262 | $0.53 | $102K | Direct | Sep 30, 2014 (7d) |
| Jan 31, 2013 | KBIO | ↑ Buy | 25,000 | $8.00 | $200K | By GBS Bioventures II A/C | Feb 4, 2013 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Brigitte Smith's insider trades
Brigitte Smith is a director at Viveve Medical (PLCSD). Since Jan 31, 2013, Brigitte has reported 3 open-market purchases worth $804K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLCSD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.